• Citer

Adverse events of targeted therapies

par Klastersky, Jean
Référence Current opinion in oncology, 26, 4, page (395-402)
Publication Publié, 2014

Article révisé par les pairs

• Détails
• Contenu

Résumé :

There is currently an explosion in the number of so-called targeted therapies. As new indications for these agents multiply, there is also an increase of new and less new side-effects. RECENT FINDINGS: Given this rapidly evolving field, any literature on that topic is rapidly obsolete and needs re-evaluation. SUMMARY: Targeted therapies are associated with a wide spectrum of adverse events, which cannot always be easily separated from the complications linked to cancer, its therapy, and comorbidities. A high awareness of these events might improve the patient's quality of life and contribute to the recognition of new syndromes. Copyright © Lippincott Williams & Wilkins.